Citation Impact
Citing Papers
A high-throughput metabolomic approach to explore the regulatory effect of mangiferin on metabolic network disturbances of hyperlipidemia rats
2014
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism
2016 Standout
A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder
2013
Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder
2012
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders
2017 Standout
Plasma Metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder
2012
Microbiota in health and diseases
2022 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Mass spectrometry‐based metabolomics
2006 Standout
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
pH- and ion-sensitive polymers for drug delivery
2013
A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease
2015
Phenolic composition and antioxidant potential of grain legume seeds: A review
2017 Standout
Advanced development in analysis of phytochemicals from medicine and food dual purposes plants used in China
2011
Determination of teniposide in rat plasma by ultra performance liquid chromatography electrospray ionization tandem mass spectrometry after intravenous administration
2009
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
2014 Standout
Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes
2015
Panax ginseng and Panax quinquefolius: From pharmacology to toxicology
2017 Standout
The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes
2011
Comparison of Salt Tolerance in Soja Based on Metabolomics of Seedling Roots
2017 Standout
Analysis of anticancer drugs: A review
2011 Standout
Botanical drugs: Challenges and opportunities
2007
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
2010
Metabolomics for bioactivity assessment of natural products
2010
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
2020 Standout
Effect of drying processes on prenylflavonoid content and antioxidant activity of Epimedium koreanum Nakai
2017
MetaboAnalyst 3.0—making metabolomics more meaningful
2015 Standout
In-silico studies in Chinese herbal medicines’ research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date
2012
Modern analytical techniques in metabolomics analysis
2011
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line
2016
Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats
2011
Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics
2010
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
2011
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Early infancy microbial and metabolic alterations affect risk of childhood asthma
2015 Standout
TrimethylamineN-Oxide, the Microbiome, and Heart and Kidney Disease
2017
Introduction to the human gut microbiota
2017 Standout
Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota
2017
Marine natural products
2018 Standout
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery
2010
The antihyperlipidemic effect of Fu-Ling-Pi is associated with abnormal fatty acid metabolism as assessed by UPLC-HDMS-based lipidomics
2015
Evaluation of the Use of Different Solvents for Phytochemical Constituents, Antioxidants, and In Vitro Anti-Inflammatory Activities of Severinia buxifolia
2019 Standout
Works of Xiumei Lu being referenced
Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression
2009
An integrated plasma and urinary metabonomic study using UHPLC–MS: Intervention effects of Epimedium koreanum on ‘Kidney-Yang Deficiency syndrome’ rats
2012
Metabonomic study on ‘Kidney-Yang Deficiency syndrome’ and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry
2010
HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric‐coated capsule
2006
Fingerprint analysis of Flos Lonicerae japonicae using binary HPLC profiling
2006
High performance liquid chromatography–electrospray ionization mass spectrometric determination of isosorbide 5-mononitrate in human plasma
2006
Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride
2009
A pharmaco‐metabonomic study on the therapeutic basis and metabolic effects of Epimedium brevicornum Maxim. on hydrocortisone‐induced rat using UPLC‐MS
2007
Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography–tandem mass spectrometry
2011
Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra‐performance liquid chromatography/mass spectrometry
2014
An 1H NMR and UPLC–MS-based plasma metabonomic study to investigate the biochemical changes in chronic unpredictable mild stress model of depression
2010
[Strategy of quality control for traditional Chinese medicines and chromatographic technology].
2006